Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of December 2019. The report addresses the status of the Company's Annual General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing.
Guidance, Outlook, and Management Commentary
The Company convened its Annual General Meeting on December 12, 2019. However, the meeting was adjourned for one week due to a lack of quorum. The Annual Meeting is scheduled to be reconvened on Thursday, December 19, 2019, at 12:00 p.m. Israel time at the Company's offices in Petach Tikva, Israel.
Key Facts for Investor Verification
- The Annual General Meeting originally scheduled for December 12, 2019, failed to achieve a quorum.
- The meeting has been rescheduled for December 19, 2019.
- This filing contains no financial performance data or updated business outlook.